Avidity Partners Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-274,300	Closed	-$20.2M	–	72
2020 Q2	$20.2M	Buy	+274,300	New	+$20.2M	1.29%	30